Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes - Takeaways - MDSpire

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

  • By

  • Quynh Chi Le

  • Mattia Longoni

  • Andrea Marmiroli

  • Fabian Falkenbach

  • Calogero Catanzaro

  • Michele Nicolazzini

  • Federico Polverino

  • Jordan A. Goyal

  • Fred Saad

  • Riccardo Schiavina

  • Luca Fabio Carmignani

  • Alberto Briganti

  • Nicola Longo

  • Markus Graefen

  • Carlotta Palumbo

  • Miriam Traumann

  • Felix K.-H. Chun

  • Pierre I. Karakiewicz

  • November 11, 2025

  • 0 min

Share

  • 1

    Partial cytoreductive nephrectomy (PCN) is a treatment option for patients with metastatic renal cell carcinoma (mRCC).

  • 2

    Robotic partial cytoreductive nephrectomy (RPCN) rates increased from 4.2% to 42.5% from 2008 to 2019, indicating a significant trend towards robotic surgery.

  • 3

    RPCN patients showed lower rates of intraoperative complications, pulmonary complications, and blood transfusions compared to open partial cytoreductive nephrectomy (OPCN) patients.

  • 4

    RPCN patients had a shorter median length of stay (2 days) compared to OPCN patients (4 days), highlighting efficiency in recovery.

  • 5

    No significant differences in overall complications, in-hospital mortality, or total hospital charges were found between RPCN and OPCN patients.

Original Source(s)

Robotic vs. open partial cytoreductive nephrectomy in metastatic renal cell carcinoma: adverse in-hospital outcomes

  • by Quynh Chi Le, Mattia Longoni, Andrea Marmiroli, Fabian Falkenbach, Calogero Catanzaro, Michele Nicolazzini, Federico Polverino, Jordan A. Goyal, Fred Saad, Riccardo Schiavina, Luca Fabio Carmignani, Alberto Briganti, Nicola Longo, Markus Graefen, Carlotta Palumbo, Miriam Traumann, Felix K.-H. Chun, Pierre I. Karakiewicz

  • November 11, 2025

Related Content

Bioinformatics Investigations Uncover the Involvement of RIPK1 in Clear Cell Renal Cell Carcinoma

C5orf46: a promising prognosis risk indicator with implication in the remodeling of KIRC and pan-cancer tumor microenvironments

Renal clear cell carcinoma with co-existing tumor thrombosis of renal vein and ureter: a case report and review of the literature